The Central Hospital of Wuhan — Wuhan, Hubei

Public research footprint of The Central Hospital of Wuhan, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Prostatic Neoplasms, Castration-Resistant · Non-paroxysmal Atrial Fibrillation · Colitis, Ulcerative

Recently updated registry entries

NCT06350890 — Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2… (Completed)
NCT07741448 — Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC (Recruiting)
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Central Hospital of Wuhan?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.